Services
THE "SPEO" MODEL
Drug Development is a lengthy and expensive process which can take years to bring an approved therapy to market. The estimated cost of drug discovery and development of a single drug was calculated to be about $ 1.8 billion and the development of a new therapeutic product (i.e. a new drug or biologics) is a long, complex and expensive process which typically takes 10 to 12 years (and sometimes more) from product identification to commercialization.
The successful implementation of these elements requires seamless integration of Strategy, Planning, Execution, and Oversight (SPEO) implemented by a skilled team that has Done it before, Is Dependable, and Delivers confidently leading to reduced time to get a drug to market and lowering your drug development costs.
At PAR Clinical we implement the SPEO (TM) Model through our exceptionally skilled teams, thus being efficient and effective to meet our client needs. Our trademark SPEO Model combines two unique service models that can be used independently or seamlessly integrated. Our team shares your passion for bringing new therapies to patients as soon as possible.
Utilizing our SPEO (TM) Model we can enhance time-critical business decision-making to achieve your organizational goals and milestones.
Please reach out to us to learn more about the SPEO Model
PLUG and PLAY Strategic Consulting Model (SPO)
Our team shares your passion for bringing new therapies to patients as soon as possible and avoiding any delays with achieving critical decision-making milestones utilizing our SPEO (TM) Model
The Plug-and-Play" Strategic Consulting Service model (SPO) is designed to empower start-up healthcare companies with the right team members who not only provide functional expertise but will help you quickly scale up your projects as the scope changes.
Our team is seasoned with usign our SPEO Model to strategically structure and managing clinical programs, asset prioritization and due diligence to enable rational and timely decision making which ultimately will reduce time to market for new therapies.
Learn more about how the SPEO Model will work for you.
Project Execution Model (E)
Project Execution Model will drive clinical studies for biotech companies as boots on the ground. We will integrate with the existing functional team as an extension of their team while driving the execution of your clinical studies at a site level.
The PAR Clinical team is an experienced and passionate group of professionals who will focus on efficiently managing your project life cycle and reduce inefficiencies and redundancies to meet strategic goals. With greater adaptability and flexibility, we will drive an efficient execution of projects while biotech companies can focus on the strategic aspects of your clinical development.
Learn more about how the SPEO Model will work for you.